BioSyntech, Inc. (“BioSyntech” or the “Company”) (TSX VENTURE: BSY) is pleased to announce the appointments of Mr. Francois Michaud C.A., C.M.A., as Chief Financial Officer and Mr. Richard Lacombe Ph.D., M.B.A., as Vice-President Clinical Affairs of the Company.
